Influence of oral rabies vaccine bait density on rabies seroprevalence in wild raccoons
Abstract The effect of different oral rabies vaccine (ORV) bait densities (75, 150, and 300 baits/km2 ) on the seroprevalence of rabies virus neutralizing antibodies (RVNAs) in raccoons ( Procyon lotor ) was assessed at a 15% seroprevalence difference threshold in rural areas of northeast Ohio. Resu...
Gespeichert in:
Veröffentlicht in: | Vaccine 2009-11, Vol.27 (51), p.7187-7193 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract The effect of different oral rabies vaccine (ORV) bait densities (75, 150, and 300 baits/km2 ) on the seroprevalence of rabies virus neutralizing antibodies (RVNAs) in raccoons ( Procyon lotor ) was assessed at a 15% seroprevalence difference threshold in rural areas of northeast Ohio. Results ( n = 588 raccoons) indicated that seropositivity for RVNAs was associated with both bait density and bait campaign frequency. Associations were not detected for raccoon gender, age, or macro-habitat. The odds of being seropositive were greater for raccoons originating from 300 bait/km2 treatment areas relative to those coming from the 75 bait/km2 areas (odds ratio [OR] = 4.4, probability [ P ] < 0.001, 95% confidence interval [CI] = 2.4–7.9), while accounting for cumulative ORV campaigns. No statistical advantage in seroprevalence was detected when comparing 150–75 baits/km2 . These results indicate that a relatively extreme bait density when evenly distributed may be necessary to obtain a significant increase in seroprevalence. Higher bait densities may be more appropriate and less costly to address focused outbreaks than labor intensive trap-vaccinate-release and local population reduction campaigns. Finally, dramatic increases in seroprevalence of RVNA were not observed in raccoons between sequential, semi-annual campaigns, yet cumulative ORV campaigns were associated with gradual increases in seroprevalence. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2009.09.035 |